ASPN PE Ratio & Valuation,Is ASPN Overvalued

ASPN Relative Valuation

ASPN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ASPN is overvalued; if below, it's undervalued.

Historical Valuation

Aspen Aerogels Inc (ASPN) is now in the Fair zone, suggesting that its current forward PS ratio of 1.15 is considered Fairly compared with the five-year average of 14.69. The fair price of Aspen Aerogels Inc (ASPN) is between 2.66 to 16.29 according to relative valuation methord.

Relative Value

Fair Zone

2.66-16.29

Current Price：3.33

Fair

-5.81

-40.47

EV/EBITDA

Aspen Aerogels Inc. (ASPN) has a current EV/EBITDA of -40.47. The 5-year average EV/EBITDA is -13.98. The thresholds are as follows: Strongly Undervalued below -91.62, Undervalued between -91.62 and -52.80, Fairly Valued between 24.85 and -52.80, Overvalued between 24.85 and 63.67, and Strongly Overvalued above 63.67. The current Forward EV/EBITDA of -40.47 falls within the Historic Trend Line -Fairly Valued range.

-5.46

EV/EBIT

Aspen Aerogels Inc. (ASPN) has a current EV/EBIT of -5.46. The 5-year average EV/EBIT is 1.53. The thresholds are as follows: Strongly Undervalued below -69.21, Undervalued between -69.21 and -33.84, Fairly Valued between 36.91 and -33.84, Overvalued between 36.91 and 72.28, and Strongly Overvalued above 72.28. The current Forward EV/EBIT of -5.46 falls within the Historic Trend Line -Fairly Valued range.

1.15

Aspen Aerogels Inc. (ASPN) has a current PS of 1.15. The 5-year average PS is 3.90. The thresholds are as follows: Strongly Undervalued below -1.97, Undervalued between -1.97 and 0.97, Fairly Valued between 6.84 and 0.97, Overvalued between 6.84 and 9.77, and Strongly Overvalued above 9.77. The current Forward PS of 1.15 falls within the Historic Trend Line -Fairly Valued range.

-23.39

P/OCF

Aspen Aerogels Inc. (ASPN) has a current P/OCF of -23.39. The 5-year average P/OCF is -7.28. The thresholds are as follows: Strongly Undervalued below -68.73, Undervalued between -68.73 and -38.01, Fairly Valued between 23.45 and -38.01, Overvalued between 23.45 and 54.17, and Strongly Overvalued above 54.17. The current Forward P/OCF of -23.39 falls within the Historic Trend Line -Fairly Valued range.

-13.08

P/FCF

Aspen Aerogels Inc. (ASPN) has a current P/FCF of -13.08. The 5-year average P/FCF is -0.65. The thresholds are as follows: Strongly Undervalued below -98.96, Undervalued between -98.96 and -49.81, Fairly Valued between 48.50 and -49.81, Overvalued between 48.50 and 97.65, and Strongly Overvalued above 97.65. The current Forward P/FCF of -13.08 falls within the Historic Trend Line -Fairly Valued range.

Aspen Aerogels Inc (ASPN) has a current Price-to-Book (P/B) ratio of 0.78. Compared to its 3-year average P/B ratio of 1.99 , the current P/B ratio is approximately -60.87% higher. Relative to its 5-year average P/B ratio of 4.00, the current P/B ratio is about -80.47% higher. Aspen Aerogels Inc (ASPN) has a Forward Free Cash Flow (FCF) yield of approximately 1.12%. Compared to its 3-year average FCF yield of -22.36%, the current FCF yield is approximately -105.03% lower. Relative to its 5-year average FCF yield of -17.75% , the current FCF yield is about -106.33% lower.

0.78

P/B

Median3y

1.99

Median5y

4.00

1.12

FCF Yield

Median3y

-22.36

Median5y

-17.75

Competitors Valuation Multiple

The average P/S ratio for ASPN's competitors is 0.63, providing a benchmark for relative valuation. Aspen Aerogels Inc Corp (ASPN) exhibits a P/S ratio of 1.15, which is 83.05% above the industry average. Given its robust revenue growth of -37.77%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of ASPN decreased by 72.28% over the past 1 year. The primary factor behind the change was an increase in P/E Change from -0.89 to -0.78.

The secondary factor is the Margin Expansion, contributed -21.54%to the performance.

Overall, the performance of ASPN in the past 1 year is driven by P/E Change. Which is more unsustainable.

-37.77%

117.34M → 73.02M

Revenue Growth

-21.54%

-11.05 → -8.67

Margin Expansion

-12.97%

-0.89 → -0.78

P/E Change

-72.28%

11.69 → 3.24

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Aspen Aerogels Inc (ASPN) currently overvalued or undervalued?

What is Aspen Aerogels Inc (ASPN) fair value?

ASPN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Aspen Aerogels Inc (ASPN) is between 2.66 to 16.29 according to relative valuation methord.

How does ASPN's valuation metrics compare to the industry average?

What is the current P/B ratio for Aspen Aerogels Inc (ASPN) as of Jan 08 2026?

As of Jan 08 2026, Aspen Aerogels Inc (ASPN) has a P/B ratio of 0.78. This indicates that the market values ASPN at 0.78 times its book value.

What is the current FCF Yield for Aspen Aerogels Inc (ASPN) as of Jan 08 2026?

As of Jan 08 2026, Aspen Aerogels Inc (ASPN) has a FCF Yield of 1.12%. This means that for every dollar of Aspen Aerogels Inc’s market capitalization, the company generates 1.12 cents in free cash flow.

What is the current Forward P/E ratio for Aspen Aerogels Inc (ASPN) as of Jan 08 2026?

As of Jan 08 2026, Aspen Aerogels Inc (ASPN) has a Forward P/E ratio of -5.81. This means the market is willing to pay $-5.81 for every dollar of Aspen Aerogels Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Aspen Aerogels Inc (ASPN) as of Jan 08 2026?

As of Jan 08 2026, Aspen Aerogels Inc (ASPN) has a Forward P/S ratio of 1.15. This means the market is valuing ASPN at $1.15 for every dollar of expected revenue over the next 12 months.

ASPN Valuation